- Home
- RMAX vs SRZN Comparison
RMAX vs SRZN Comparison
Compare RMAX & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$24.85
Company Overview
Basic Information| Metric | RMAX | SRZN |
|---|---|---|
| Founded | 1973 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.9M | 164.3M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | RMAX | SRZN |
|---|---|---|
| Price | $6.96 | $24.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $9.00 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 174.4K | 153.7K |
| Earning Date | 02-19-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | ★ $292,931,000.00 | $3,604,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.36 | N/A |
| P/E Ratio | $11.48 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.90 | $5.90 |
| 52 Week High | $10.61 | $25.47 |
Technical Indicators
Market Signals| Indicator | RMAX | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 35.86 | 61.76 |
| Support Level | $7.11 | $21.07 |
| Resistance Level | $7.79 | $23.78 |
| Average True Range (ATR) | 0.31 | 2.38 |
| MACD | -0.07 | 0.26 |
| Stochastic Oscillator | 15.69 | 82.83 |
Price Performance
Historical Comparison RMAX
SRZN
About RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).